Decoy Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 0.00 shares.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 0.00 shares.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- Decoy Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-08 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 0.00 shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 0.00 shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-08 | 0.00 shares derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 0.00 shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 0.00 shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-14 | 0.00 shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | 0.00 shares 10-K · filed 2025-03-21 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 0.00 shares derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-13 | 0.00 shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | 0.00 shares 10-K · filed 2024-03-22 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 0.00 shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 0.00 shares 10-K · filed 2023-03-27 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | 0.00 shares derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-12 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | 0.00 shares 10-K · filed 2022-03-25 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | 0.00 shares 10-K · filed 2021-03-18 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-17 | 0.00 shares derived: sum of 4 quarters · filed 2019-07-17 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-01 | 84.67K shares derived: sum of 4 quarters · filed 2019-05-01 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 97.31K shares 10-K · filed 2019-03-06 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | 97.66K shares derived: sum of 4 quarters · filed 2019-03-06 |
| 2018-06-30 | 84.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 97.66K shares derived: sum of 4 quarters · filed 2019-03-06 |
| 2018-03-31 | 12.64K shares 10-Q · filed 2018-05-02 | 14.22K shares derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-12-31 | 350.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 1.58K shares 10-K · filed 2019-03-06 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | 1.23K shares derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-06-30 | 1.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 3.34K shares derived: sum of 4 quarters · filed 2019-03-06 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-03 | 2.70K shares derived: sum of 4 quarters · filed 2019-03-06 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 8.52K shares 10-K · filed 2019-03-06 |
| 2016-09-30 | 2.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | 9.68K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | 584.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | 11.95K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | 5.82K shares 10-Q · filed 2016-05-04 | 16.03K shares derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | 1.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 47.28K shares 10-K · filed 2018-03-07 |
| 2015-09-30 | 4.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | |
| 2015-06-30 | 4.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | |
| 2015-03-31 | 37.06K shares 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |